Magee, Gray H.
Grunwald, Michael R.
Funding for this research was provided by:
Wake Forest University
Article History
Accepted: 30 July 2025
First Online: 23 August 2025
Declarations
:
: This article does not contain any studies with human or Animal Subjects performed by any of the authors.
: GHM has no competing interests. MRG has received consulting fees from Amgen, Aptitude Health, Astellas, Blueprint Medicines, Cardinal Health, Cogent Biosciences, Daiichi Sankyo, Disc Medicine, Incyte, Janssen, OncLive, Premier, Sanofi, Servier, Sobi, and Takeda; research support from Ajax, Incyte, and Janssen; and has stock ownership in Medtronic.